Evidence map›Paper›PMID 41821097›Full record

ArticleBMC research notes2026

Automated image-based classification of rat fecal consistency using an object-detection tool.

Erika Mori, Satoru Nishibashi, Ippei Yamaoka

Abstract read
In one paragraph

Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erika MoriMedical Foods Research Institute, Otsuka Pharmaceutical Factory, Inc, 115 Kuguhara, Tateiwa, Muya-cho, Naruto, Tokushima, 772-8601, Japan.
Satoru NishibashiICT Solution Department, Otsuka Pharmaceutical Factory, Inc, Naruto, Tokushima, 772-8601, Japan.
Ippei YamaokaMedical Foods Research Institute, Otsuka Pharmaceutical Factory, Inc, 115 Kuguhara, Tateiwa, Muya-cho, Naruto, Tokushima, 772-8601, Japan. yamaokai@otsuka.jp.

Funding

Otsuka Pharmaceutical Factory No specific grant number
6 · The paper itself

Abstract

objectiveManual classification of rat fecal consistency is widely used in gastrointestinal and pharmacological research, but it is highly inefficient and exposes researchers to allergens due to frequent defecation and continuous handling. Automated image-based analysis addresses a gap in high-throughput experimental workflows by reducing human error and improving scalability. Therefore, this study aimed to develop an artificial intelligence (AI) model using the YOLOv5-L6 object-detection framework to automate the classification of fecal consistency into four categories: normal, soft, muddy, and watery. Moreover, the efficiency and reproducibility of the proposed framework are compared with manual methods.

resultsA dataset of 95 images containing 1,667 labeled fecal samples was prepared with augmentation techniques to enhance robustness. The trained model achieved a mean average precision (mAP) of 86.2%, with class-specific average precision ranging from 75.5% to 95.4%. Compared with manual classification, which required an average of 45 ± 11.3 min, the AI-based approach completed initial classification in 53 s. Moreover, by including manual correction of misclassifications, the total time was approximately 8 min, representing an 82% reduction in processing time. These findings demonstrate that AI-based object detection can substantially improve workflow efficiency in preclinical research.

Indexed as

Artificial IntelligenceFecesImage Processing, Computer-AssistedAnimalsDetection AlgorithmsIntelligent SystemsRatsReproducibility of ResultsArtificial intelligenceDiarrheaFecal stoolsObject detectionRats

Identifiers

PMID41821097
PMCPMC13097713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.